IQE PLC Iqe Plc : Director/Pdmr Shareholding
July 28 2017 - 9:27AM
UK Regulatory
TIDMIQE
28 July 2017
IQE plc ("IQE" or the "Company")
Director/PDMR Shareholding
IQE plc (AIM: IQE) was notified on 25 July 2017 and 27 July 2017 that Dr
Andrew Nelson, CEO of the Company, sold a total of 5,800,000 ordinary
shares of 1 pence each in the Company ("Ordinary Shares"), with the two
sales executed at a gross average price of 106.04 pence per Ordinary
Share. The Company was also notified on 25 July 2017 that Dr Godfrey
Ainsworth, Chairman of the Company, sold 1,000,000 Ordinary Shares, with
the sale executed at a gross average price of 105.14 pence per Ordinary
Share (together, the "Transactions"). The Transactions were completed on
25 July 2017 and 27 July 2017.
Dr Ainsworth accumulated his shareholding exclusively through share
purchases during the period since the Company's IPO in 1999. Dr Nelson
accumulated his shareholding through a combination of founder shares,
share purchases and LTIP awards since the start of the company in 1988.
These Transactions are for future retirement planning purposes, and in
the case of Dr Nelson, the sale of shares was made to secure the
required funds to repay an existing loan which was used to purchase
shares in the Company. This loan was previously announced on 14 October
2014 and the loan is due to repayment on 10 October 2017. It is Dr
Nelson's intention that he will repay the existing loan ahead of the
repayment date and a further announcement will be made in due course
upon repayment of this loan. Dr Nelson and Dr Ainsworth remain fully
committed to the Company and have no plans to sell any further shares at
this time.
Post the Transactions, Dr Nelson's total holding comprises of 29,459,218
Ordinary Shares (which includes 18 million shares that are subject to an
obligation to repurchase as part of a loan agreement announced on 13(th)
November 2014), representing 4.31% of the Company's issued share capital,
and 3,145,433 unexercised fully vested options over Ordinary Shares. Dr
Ainsworth's total remaining holding comprises of 2,154,197 Ordinary
Shares, representing 0.32% of the Company's issued share capital. In
addition, Dr Nelson has 7,532,962 share options, which vest in January
2019 subject to performance criteria.
The notification set out below is provided in accordance with the
requirements of the EU Market Abuse Regulation.
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1. Details of the Person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Dr Andrew Nelson
2. Reason for the notification
a) Position / status PDMR (CEO)
b) Initial notification / Initial notification
amendment
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name IQE plc
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
a) Description of the Ordinary shares of 1 pence each in the Company
financial instrument GB0009619924
b) Nature of the transaction Sale of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
105.14 pence 5,000,000 Ordinary Shares
111.66 pence 800,000 Ordinary Shares
d) Aggregated information
-- Aggregated volume 5,800,000 Ordinary Shares
106.04 pence per Ordinary Share
-- Aggregated price Total consideration of GBP6,150,345.40
-- Aggregated total
e) Date of the transaction(s) 25 July 2017 and 27 July 2017
f) Place of the transaction London Stock Exchange, AIM
1. Details of the Person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Dr Godfrey Ainsworth
2. Reason for the notification
a) Position / status PDMR (Chairman)
b) Initial notification / Initial notification
amendment
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name IQE plc
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
a) Description of the Ordinary shares of 1 pence each in the Company
financial instrument GB0009619924
b) Nature of the transaction Sale of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
105.14 pence 1,000,000 Ordinary Shares
d) Aggregated information
-- Aggregated volume 1,000,000 Ordinary Shares
105.14 pence per Ordinary Share
-- Aggregated price Total consideration of GBP1,051,411.00
-- Aggregated total
e) Date of the transaction 25 July 2017
f) Place of the transaction London Stock Exchange, AIM
Contacts:
IQE plc
Drew Nelson
Phil Rasmussen
Chris Meadows +44 (0) 29 2083 9400
Canaccord Genuity
Simon Bridges
Henry Fitzgerald-O'Connor
Richard Andrews + 44 (0) 20 7523 8000
Peel Hunt
Euan Brown +44 (0) 20 7418 8900
This announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: IQE plc via Globenewswire
http://www.iqep.com
(END) Dow Jones Newswires
July 28, 2017 09:27 ET (13:27 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Iqe (LSE:IQE)
Historical Stock Chart
From Apr 2024 to May 2024
Iqe (LSE:IQE)
Historical Stock Chart
From May 2023 to May 2024